Peptide LocalCompare price, evidence & access
Search /Compare vendors
Locations/United Kingdom/CagriSema
Purchase and availability checkCagriSema in the United Kingdom

Can you buy CagriSema in the United Kingdom?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. CagriSema is an investigational clinical program.

Direct answers →Open official records →Open the interactive status check
Evidence lane
Investigational clinical program
Destination
United Kingdom
Source records
3
Reviewed
24 July 2026
ByPeptide Local Editorial DeskUpdated 24 July 2026How we review
Direct answers

What this exact search can and cannot establish.

Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.

01

Can you buy CagriSema in the United Kingdom?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. CagriSema is an investigational clinical program. No seller listing in the United Kingdom can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below. Before acting on an offer, match the exact product, authorization, seller identity, and supply route in the official records below.

02

Which official records should be checked for CagriSema in United Kingdom?

Resolve the exact identity of CagriSema through REDEFINE 1 Phase 3 study - NCT05567796 from ClinicalTrials.gov. Then search Search licensed medicine product information from Medicines and Healthcare products Regulatory Agency for the destination product record and Search the register from General Pharmaceutical Council for the seller, establishment, or supply route in United Kingdom. A match in one record does not replace the other two checks.

03

Does an online listing prove CagriSema is authorized or available in United Kingdom?

No. A page using the name CagriSema, local currency, a domestic delivery claim, or a familiar package image is only a lead. This is an investigational program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For United Kingdom, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.

Live trial footprint

CagriSema clinical trials in United Kingdom

8 study records currently list 89 locations in this country, including 3 locations individually marked Recruiting.

Registry update: 24 July 2026
Study records
8
Listed locations
89
Recruiting locations
3
Records with local recruiting sites
1
NCT07253285
Study-wide statusRecruiting

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Listed locations
3
Recruiting locations
3
Registry update
2026-07-17
NCT05567796
Study-wide statusActive, not recruiting

A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight

Listed locations
14
Recruiting locations
0
Registry update
2026-07-17
NCT05669755
Study-wide statusActive, not recruiting

REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels

Listed locations
23
Recruiting locations
0
Registry update
2026-07-17
NCT06065540
Study-wide statusCompleted

A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

Listed locations
12
Recruiting locations
0
Registry update
2026-07-08
NCT06388187
Study-wide statusCompleted

A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight

Listed locations
6
Recruiting locations
0
Registry update
2026-05-05
NCT05394519
Study-wide statusCompleted

A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight

Listed locations
17
Recruiting locations
0
Registry update
2026-01-28
Continue the exact comparison

Related country and compound records.

Compare another tracked name in United Kingdom, or keep CagriSema fixed and change the destination within Europe. The identity, product, and seller checks remain separate.

Continue the exact comparison

CagriSema in Europe

CagriSema across 42 countries
Identity before availability

A name alone cannot establish a local verdict.

CagriSema is an investigational clinical program. No seller listing in the United Kingdom can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below.

Primary identity source: REDEFINE 1 Phase 3 study - NCT05567796 / ClinicalTrials.gov ↗
Three-record verification path

Identity. Product. Seller or supply.

A credible result must keep these separate. The official links answer different questions and should be checked in sequence.

REDEFINE 1 Phase 3 study - NCT05567796

REDEFINE 1 Phase 3 study - NCT05567796 is maintained by ClinicalTrials.gov. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open REDEFINE 1 Phase 3 study - NCT05567796 ↗

Search licensed medicine product information

Search licensed medicine product information is maintained by Medicines and Healthcare products Regulatory Agency. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Search licensed medicine product information ↗

Search the register

Search the register is maintained by General Pharmaceutical Council. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Search the register ↗
United Kingdom / Country guide

United Kingdom market context.

A website can look clinical without being a registered pharmacy. The GPhC register is the relevant check for Great Britain pharmacy premises and professionals.

  • The GPhC provides a public register for pharmacy professionals and premises in Great Britain.
  • MHRA publishes safety information and enforcement updates for medicines and medical products.
  • A UK price table will launch only after the seller class and delivery claims are verified.
Destination checklist

Repeat the country checks before comparing any offer.

The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.

01

Check the register

Confirm pharmacy premises and professional details in the official GPhC register.

02

Separate categories

Do not treat a laboratory chemical listing as a substitute for a prescribed medicine.

03

Record the evidence

Keep the seller, batch document, currency, VAT, delivery limit, and date checked together.

Primary evidence

Audit every source used by this page.

Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.

01
NCT05567796: A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose WeightClinicalTrials.gov
02
Search licensed medicine product informationMedicines and Healthcare products Regulatory Agency
03
Search the registerGeneral Pharmaceutical Council
04
Medicines safety guidanceMHRA
05
CagriSema study search in United KingdomClinicalTrials.gov
06
NCT07253285: A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body WeightClinicalTrials.gov
07
NCT05669755: REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood VesselsClinicalTrials.gov
08
NCT06065540: A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 InhibitorClinicalTrials.gov
09
NCT06388187: A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose WeightClinicalTrials.gov
10
NCT05394519: A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose WeightClinicalTrials.gov
Audit and handoff

Keep the exact record attached.